Aprogen Pharmaceuticals Inc (003060) — Free Cash Flow Generation Index
Aprogen Pharmaceuticals Inc (003060) has a Free Cash Flow Generation Index of 0.13x as of December 2022. Free cash flow of ₩85.90 Million represents 0% of operating cash flow (₩676.93 Million). See working capital position of Aprogen Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Aprogen Pharmaceuticals Inc Free Cash Flow Generation Index (2010–2022)
Historical FCF Generation Index trend for Aprogen Pharmaceuticals Inc across 7 annual periods. Explore Aprogen Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Aprogen Pharmaceuticals Inc (2010–2022)
Year-by-year Free Cash Flow Generation Index for Aprogen Pharmaceuticals Inc. For the full company profile including market capitalisation, see Aprogen Pharmaceuticals Inc market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.94x | ₩24.18 Billion | ₩25.73 Billion | ₩1.55 Billion | ▲ +14.0% |
| 2020 | 0.82x | ₩6.67 Billion | ₩8.09 Billion | ₩976.29 Million | ▲ +134.5% |
| 2019 | -2.39x | ₩-1.71 Billion | ₩713.73 Million | ₩2.13 Billion | ▼ -248.9% |
| 2018 | -0.69x | ₩-912.93 Million | ₩1.33 Billion | ₩1.01 Billion | ▼ -109.4% |
| 2016 | 7.27x | ₩3.27 Billion | ₩449.98 Million | ₩2.82 Billion | ▲ +86.0% |
| 2015 | 3.91x | ₩7.22 Billion | ₩1.85 Billion | ₩5.37 Billion | ▼ -92.3% |
| 2010 | 50.52x | ₩12.52 Billion | ₩247.92 Million | ₩12.28 Billion | — |